Getting to Equal 2019

A culture of equality is a powerful multiplier of innovation and growth, making it a business priority that could increase global GDP by $8 trillion by 2028, finds this report by Accenture

Six elements of an 'innovation mindset':

  • Purpose: Alignment around and support for the purpose of the organisation
  • Resources: Having the tools, time and incentives necessary to innovate
  • Collaboration: Working with other departments or in fluid, cross-functional teams
  • Autonomy: Being shown a clear mandate for change and being trusted to deliver this
  • Inspiration: Tapping into inspiration from beyond the organisation
  • Experimentation: exploring new ideas quickly without fear of failure




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Europe's AI Reckoning: Reinve...

Europe’s productivity challenge is growing and the clear root cause is underinvestment in technology. In this report, Criticaleye Partner Accenture explores the potential of artificial intelligence (AI) to bo...

Click here to download this insight
Are Women Leaders Driving our...

How are women leaders responding to disruption in today’s uncertain world? This report from Criticaleye Partner AlixPartners draws on insights from its latest Disruption Index to reveal that women in leadership ar...

Click here to download this insight
CEO Research Results 2025

This research, conducted at our CEO Retreat, subtitled When Leadership Goes Faster, provides a fascinating insight into the challenges and priorities for CEOs this year. Key findings from Criticaleye's CEO Resear...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 480




Amazon UK Salesforce Workday Hitachi Solutions Google Royal London Group Palo Alto Networks AlixPartners LDC Concentrix NATS Experian Legal & General Investment Management Drax Group plc London Stock Exchange Group Lightsource bp Rolls-Royce Eightfold AI IBM Consulting Redwood Bank E.ON UK FTSE Women Leaders Review Accenture GlaxoSmithKline plc